VeriMompalmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine은 임신 중 안전한가요?
No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
성분
palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
알려진 위험 없음100
/100
0
Pregnancy-safe products containing palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
Matte
Matte Growth Factor Serum
99/100
ISOMERS Skincare
ISOMERS Skincare Stemgenesis® Pur Orchid Concentrate
99/100
TAHNYC
TAHNYC Contour Concentrated 10 Peptide Serum
99/100
HighDroxy
HighDroxy Re:store Ageless
98/100
Basiclab
Basiclab Esteticus Skin Structure Regenerating Serum with 1% Ceramides and 5% Peptides
98/100
Bigger Than Beauty
Bigger Than Beauty Light Weight Moisturizer
98/100
RevivSerums
RevivSerums Telomerase 6-In-1 Multi-Corrective Serum
98/100
The Neo Mortal
The Neo Mortal Hand And Body Balm V6
98/100
Beverly Hills MD
Beverly Hills MD Line Smoothing Serum™
98/100
Nécessaire
Nécessaire Hand Cream *2023 Update*
98/100
Related ingredients
Frequently asked questions
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine은 임신 중 안전한가요?
- No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine은 모유 수유 중 안전한가요?
- No data indicating transfer into breast milk or lactation-related toxicity. Given the peptide's size/polarity and expected negligible systemic absorption after topical use, risk of exposure to breastfed infants is unlikely. No regulatory flags (ECHA Annex VI, SCCS, CIR) or peer‑reviewed evidence were found.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine은 아기 피부에 안전한가요?
- No infant‑specific reproductive or toxicology data located. Adult dermal absorption is expected negligible; however, infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, so exposure score is increased by +1 for 0–3 yr. There is still no mechanistic or hazard evidence suggesting reproductive or developmental toxicity for infants.
- VeriMom은 palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.